The Beijing Winter Olympics has raised the curtain on Feb 4, 2022, as thousands of athletes from across the globe gather in China for the first international multi-sport event to be held as scheduled since the COVID-19 pandemic.
CapitalBiotech, as a member of the national team to fight against the epidemic during the Beijing Winter Olympics and Winter Paralympics, assumed the responsibility for the detection of Covid-19 for high officials & royal family members from all over the world. Our anti-epidemic "Light Cavalry" - the COVID-19 Mobile Laboratory, is on the frontier to support the 2022 Beijing Winter Olympics.
Being equipped with SARS-CoV-2 Integrated Microfluidic Chip Analysis System, which LoD is 150 copies/ml, developed by CapitalBiotech, the "Light Cavalry" can complete the whole experiment within 45 min. The SARS-CoV-2 Integrated Microfluidic Chip Analysis System was awarded The First Prize and "2021 CAETS Communication Award - Engineering Achievement" issued by CAETS (Council of International Academy of Engineering) in 2021.
The SARS-CoV-2 Integrated microfluidic platform also played an important role in the prevention and control of the CCTV Spring Festival Gala in 2021 and 2022, as well as in major events such as the 100-day countdown to the opening of the 2022 Winter Olympics. The operator only needs to add the sample preservation solution to the chip, and start the machine after sealing the chip. The hands-on time is less than 1 minute. The whole process of biological reaction (including nucleic acid extraction, nucleic acid purification, amplification reaction, nucleic acid detection, result interpretation, etc.) is integrated into a microfluidic chip with an overall airtight and internal partition, which is completed by an automatic nucleic acid analyzer. Therefore, it can work in any environment without the need for professional partitioning Laboratories.
Next Generation Sequencing (NGS) TechnologyApril 8, 2024Next Generation Sequencing (NGS), also known as high-throughput sequencing, revolutionized the field of genomics. Unlike traditional Sanger sequencing methods, NGS allows researchers to analyze vast a...view
Is a Microarray Platform Right for Gene Expression?November 10, 2023When it comes to gene expression analysis, microarray platforms are a popular choice for researchers around the world. But is a microarray platform right for your specific needs? In this article, we w...view
Diagnosis of Colorectal Cancer from Three AspectsApril 4, 2023Coloretal cancer is a common digestive tract tumor with high malignancy. If it is not detected timely, the patient's condition is usually already in the middle or late stages. There are three main...view